TORCH Panel Test: Congenital Infections and How to Read the Serology

A woman in her first trimester tells you her previous pregnancy ended in stillbirth, and this time she has had a low-grade fever and a faint rash. Her obstetrician orders a "TORCH screen." The result comes back with a list of IgG and IgM values against five organisms, and the real work begins: not which organisms are positive, but what each positive and negative actually means for this pregnancy and this baby.

A TORCH panel is easy to order and easy to misread. This article is about reading it well.

What TORCH stands for, and why these infections are grouped

TORCH is an acronym for a group of infections that share one dangerous property: they cause mild or silent illness in the mother but can cross the placenta and seriously harm the developing fetus. They are grouped not because they are biologically related, they are a parasite, several viruses, and a bacterium, but because they behave the same way in pregnancy and are investigated the same way.

The letters stand for Toxoplasmosis, Other, Rubella, Cytomegalovirus, and Herpes simplex virus. Prenatal infections of this kind account for a small percentage of all congenital anomalies, but the anomalies they cause are severe and often preventable, which is why they are screened for as a group.

This article covers what these organisms have in common: why they matter in pregnancy, how the panel is interpreted, and what a result does and does not tell you. Where you need the detail of a single organism, follow the link for that letter.

T: Toxoplasma gondii. A protozoan parasite acquired from cat feces or undercooked meat. Primary infection in pregnancy can cause intracerebral calcifications, chorioretinitis, and hydrocephalus. Read more about Toxoplasma.

O: Other. The acronym could not list every relevant agent, so "Other" is a deliberate catch-all. The classic members are syphilis (Treponema pallidum), varicella-zoster virus, and parvovirus B19. Several more organisms also cross the placenta and are often included in the same clinical thinking: HIV, hepatitis B, and Listeria monocytogenes. Of these, congenital syphilis deserves particular attention in many settings because it is common, damaging, and preventable with treatment. Find more about the laboratory diagnosis of syphilis.

R: Rubella. A mild viral rash illness in the mother, but a first-trimester infection is a classic cause of congenital rubella syndrome: sensorineural deafness, cataracts, and congenital heart disease. Read more about rubella virus.

C: Cytomegalovirus. The commonest congenital viral infection worldwide and the leading non-genetic cause of childhood sensorineural hearing loss. Often silent at birth. Read more about cytomegalovirus.

H: Herpes simplex virus. Unlike the others, HSV is usually transmitted perinatally, during passage through an infected birth canal, rather than across the placenta. This distinction matters and is explained below. Read more about herpes simplex virus.

The one property they share: mild in the mother, serious for the fetus

The reason a TORCH panel exists is a single clinical pattern that repeats across all these organisms. The maternal infection is typically mild, and often entirely without symptoms, so it cannot be relied on to predict fetal outcome. Yet the same infection, reaching the fetus at the wrong time, can cause death, miscarriage, or permanent damage. Because the mother's illness is a poor guide, laboratory testing carries the diagnostic weight.

For most of these organisms, treating the mother's infection does little or nothing to reverse damage already done to the fetus. There are important exceptions, maternal toxoplasmosis and maternal syphilis can be treated in ways that reduce fetal harm, so the older teaching that "treatment of the mother has no effect on the fetus" is an overstatement. But the general thrust holds: prevention and early detection matter far more than late treatment, which is why counselling and screening dominate the clinical approach.

Timing: why the same infection is worse earlier and more likely later

The single most important concept for reading congenital infection is that two things change across pregnancy, and they change in opposite directions.

The risk of transmission to the fetus generally rises as pregnancy advances. Later in gestation, the placenta is more likely to let the organism through.

The severity of fetal damage generally falls as pregnancy advances. Early pregnancy is when organs are forming, so an infection then is the most likely to cause severe structural defects.

Put together: an infection in the first trimester is the least likely to reach the fetus but the most devastating when it does; an infection in the third trimester is the most likely to be transmitted but the least likely to cause severe malformation. This is why the first question about any positive result is always how many weeks.

Two worked examples anchor the pattern. Rubella is the severe-early archetype: first-trimester infection carries the highest risk of the full congenital rubella syndrome. Cytomegalovirus shows the gradient in numbers: transmission after a primary maternal infection rises from roughly one in five in the first trimester to a majority by the third, while the worst outcomes cluster in early infection.

Primary versus prior infection: the question the panel is really asking

The fetus is endangered mainly by a mother's first (primary) infection during pregnancy, because she has no pre-existing antibody to contain the organism before it crosses the placenta. A mother infected and immune before pregnancy usually passes protective IgG to the fetus instead of the organism.

This is the logic the antibody panel is built to detect, and it rests on the behavior of two antibody classes:

IgM appears first and means recent. It is the marker of current or recent infection. Crucially, IgM does not cross the placenta.

IgG appears later and means immunity or past exposure. It persists for years and, importantly, does cross the placenta.

From these two facts, the whole interpretation follows.

Reading the panel

In the mother:

IgG positive, IgM negative usually means past infection and existing immunity, generally reassuring, because prior immunity protects the fetus.

IgG negative, IgM negative means the mother is susceptible: not infected, but not immune either. She has no protection and should be counselled on prevention (and, for rubella, vaccinated after delivery).

IgM positive raises the possibility of recent or current infection, the situation of concern, but it must be confirmed, because IgM has two well-known traps described below.

In the newborn:

IgG in a newborn is unreliable on its own, because it may simply be the mother's antibody that crossed the placenta. A positive neonatal IgG can reflect maternal immunity, not fetal infection.

IgM in a newborn is the meaningful result. Maternal IgM does not cross the placenta, so IgM detected in the infant must have been produced by the infant, which indicates true infection in the womb.

Two traps in IgM interpretation

IgM can persist, so "positive" does not always mean "just now." For some organisms, most notably Toxoplasma, IgM can remain detectable for months to over a year after infection. A positive IgM in early pregnancy might therefore reflect an infection acquired before conception, which would not threaten the fetus. This is resolved with an IgG avidity test: antibodies from a recent infection bind weakly (low avidity), while antibodies from an older infection bind tightly (high avidity). High-avidity IgG early in pregnancy points to infection before conception and is reassuring.

Rubella is a useful counter-example. Because rubella IgM wanes within about two months, a positive rubella IgM is more trustworthy as a sign of genuinely recent infection.

Prior immunity is not always absolute. For most TORCH agents, prior maternal immunity effectively protects the fetus. Cytomegalovirus is the exception: a previously immune mother can still, uncommonly, transmit the virus through reactivation or reinfection, so a reassuring IgG pattern does not entirely exclude congenital CMV.

The HSV exception: perinatal, not transplacental

Herpes simplex virus sits inside the acronym but behaves differently from the rest. The other TORCH agents mainly damage the fetus by crossing the placenta during pregnancy. HSV, by contrast, is usually acquired perinatally, when the newborn passes through a birth canal carrying active herpes lesions or shedding virus.

This changes the clinical approach: the concern is the mode and timing of delivery in a mother with genital herpes, rather than antibody surveillance across trimesters. A student who lumps HSV with the transplacental agents will misunderstand both how it is transmitted and how it is prevented.

Should TORCH be ordered as a single panel at all?

It is worth knowing the modern criticism of the TORCH panel. Ordering all the tests reflexively as a bundle, without a specific clinical question, produces results that are hard to interpret: a scatter of IgG positives that mostly reflect old, harmless immunity, and occasional IgM positives that trigger anxiety and further testing.

Many authorities now favor targeted testing driven by the clinical picture, maternal history, exposure, ultrasound findings, over a blanket panel.

How to Remember

TORCH is a behavior, not a family. The organisms are unrelated, a parasite, viruses, and a bacterium, but they act alike: mild in the mother, dangerous to the fetus, detected by serology. The acronym groups them by what they do, not what they are.

Transmission up, severity down. As pregnancy advances, the fetus is more likely to be infected but less likely to be severely harmed. First trimester is low-risk to catch, high-risk to devastate.

IgM stays with the baby; IgG comes from the mother. Maternal IgM cannot cross the placenta, so any IgM in a newborn is the infant's own and proves true fetal infection. IgG does cross, so a newborn's IgG may just be borrowed maternal antibody. This single fact drives all neonatal interpretation.

H is the odd one out. Herpes is perinatal, not transplacental. It rides in the acronym but is caught at delivery, not across the placenta.

Key exam facts in one table

Where Students Get Confused

A positive TORCH IgG means the baby is at risk. Usually the opposite. In the mother, IgG positive with IgM negative generally means old immunity, which protects the fetus. The result that raises concern is a positive IgM, and even that must be confirmed.

The TORCH organisms are biologically related. They are not. TORCH groups a protozoan, several viruses, and a bacterium purely by their shared behavior in pregnancy.

Later infection in pregnancy is more dangerous because transmission is higher. Transmission does rise later, but severity falls. First-trimester infection is the most damaging even though it is transmitted least often. The two trends move in opposite directions.

A positive IgM always means a fresh infection threatening this pregnancy. Not for every organism. Toxoplasma IgM in particular can persist long after the infection, so a positive result early in pregnancy may reflect infection acquired before conception. IgG avidity testing settles the timing.

Herpes threatens the fetus across the placenta like the others. HSV is usually acquired at delivery, not transplacentally. The clinical focus is the birth, not trimester-by-trimester antibody surveillance.

If the mother is immune, congenital infection is impossible. True enough for rubella and toxoplasmosis, but cytomegalovirus can still be transmitted despite prior immunity. Prior immunity greatly lowers but does not always eliminate the risk.

References

• Riedel S, Hobden JA, Miller S, et al. Jawetz, Melnick & Adelberg's Medical Microbiology. 28th ed. New York: McGraw Hill; 2019.
• Levinson W, Chin-Hong P, Joyce EA, Nussbaum J, Schwartz B. Review of Medical Microbiology and Immunology. 17th ed. New York: McGraw Hill; 2022.
• Neu N, Duchon J, Zachariah P. TORCH infections. Clin Perinatol. 2015;42(1):77–103. https://doi.org/10.1016/j.clp.2014.11.001
• Leeper C, Lutzkanin A. Infections During Pregnancy. Prim Care. 2018;45(3):567–586. https://doi.org/10.1016/j.pop.2018.05.013